A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome

Định dạng: PDF / Số trang: 8

Nhắn tin với admin nếu không tải được